大东方：A股股价异常波动，前三季营收及净利润双降

Core Viewpoint - The company announced an abnormal stock price fluctuation with a cumulative increase of 24.74% over three consecutive trading days in November 2025, indicating potential volatility in the stock market [1] Financial Performance - For the first three quarters of 2025, the company's revenue was 2.645 billion yuan, a year-on-year decrease of 4.23% [1] - The net profit for the same period was 55.6589 million yuan, reflecting a year-on-year decline of 33.12%, highlighting the risk of performance deterioration [1] Market Valuation - As of November 16, the company's price-to-earnings (P/E) ratio stood at 113.14, significantly higher than the average P/E ratio of 40.39 for the "medical services" industry, suggesting potential overvaluation and caution for investors [1]